Proteasome activity in human lens nuclei and correlation with age, gender and severity of cataract

Current Eye Research

Volumn 27, Issue 1, 2003, Pages 45-53

  Zetterberg, Madeleine ^a,b   Petersen, Anne ^a   Sjöstrand, Johan ^a   Karlsson, Jan Olof ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Ageing; Cataract; Lens nucleus; Proteasome; Proteolysis

Indexed keywords

CHYMOTRYPSIN; PEPTIDASE; PROTEASOME; PROTEINASE;

AGING; APOPTOSIS; ARTICLE; CATALYSIS; CATARACT EXTRACTION; COMPLEX FORMATION; DISEASE SEVERITY; ENZYME ACTIVE SITE; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; HYDROLYSIS; LENS EPITHELIUM; LENS NUCLEUS; PRIORITY JOURNAL; PROTEIN DEGRADATION;

AGING; CATARACT; CHYMOTRYPSIN; CYSTEINE ENDOPEPTIDASES; ENDOPEPTIDASES; HUMANS; LENS NUCLEUS, CRYSTALLINE; MULTIENZYME COMPLEXES; PEPTIDE HYDROLASES; PROTEASOME ENDOPEPTIDASE COMPLEX; SEVERITY OF ILLNESS INDEX; SEX CHARACTERISTICS; TRYPSIN;

EID: 0041704857     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.1076/ceyr.27.2.45.15457     Document Type: Article

References (37)

1. Coux O, Tanaka K, Goldberg AL. Structure and functions of the 20s and 26s proteasomes. Annu Rev Biochem. 1996;65:801-847.
2. Baumeister W, Lupas A. The proteasome. Curr Opin Struct Biol. 1997;7:273-278.
3. Baumeister W, Walz J, Zuhl F, Seemuller E. The proteasome: Paradigm of a self-compartmentalizing protease. Cell. 1998;923:367-380.
4. Rivett AJ. Preferential degradation of the oxidatively modified form of glutamine synthetase by intracellular mammalian proteases. J Biol Chem. 1985;2601:300-305.
5. Murakami K, Jahngen JH, Lin SW, Davies KJA, Taylor A. Lens proteasome shows enhanced rates of degradation of hydroxyl radical modified alpha-crystallin. Free Radic Biol Med. 1990;8:217-222.
6. Goldberg AL, Gaczynska M, Grant E, Michalek M, Rock KL. Functions of the proteasome in antigen presentation. Cold Spring Harb Symp Quant Biol. 1995;60:479-490.
7. Orlowski M, Cardozo C, Michaud C. Evidence for the presence of five distinct proteolytic components in the pituitary multicatalytic proteinase complex. Properties of two components cleaving bonds on the carboxyl side of branched chain and small neutral amino acids. Biochemistry. 1993;32:1563-1572.
8. Waley SG, van Heyningen R. Neutral proteinases in the lens. Biochem J. 1962;83:274-283.
9. Ray K, Harris H. Purification of neutral lens endopeptidase: Close similarity to a neutral proteinase in pitituary. Proc Natl Acad Sci USA. 1985;82:7545.
10. Wagner BJ, Margolis JW, Farnsworth PN, Fu S-CJ. Calf lens neutral proteinase activity using calf lens crystallin substrates. Exp Eye Res. 1982;35:293-303.
11. Trayhurn P, van Heyningen R. Neutral proteinase activity in the human lens. Exp Eye Res. 1976;22:251-257.
12. Fleshman KR, Margolis JW, Wagner BJ. Age changes in bovine lens endopeptidase activity. Mech Ageing Dev. 1985;311:37-47.
13. Fleshman KR, Wagner BJ. Changes during aging in rat lens endopeptidase activity. Exp Eye Res. 1984;39:543-551.
14. Blow AMJ, van Heyningen R, Barrett AJ. Metal-dependent proteinase of the lens. Biochem J. 1975;145:591-599.
15. Harding J, Crabbe MJC. The lens: Development, proteins, metabolism and cataract. In: Davson H. The Eye. London: Academic Press; 1984:207-492.
16. Bessems GJ, Hoenders HJ, Wollensak J. Variation in proportion and molecular weight of native crystallins from single human lenses upon aging and formation of nuclear cataract. Exp Eye Res. 1983;376:627-637.
17. Dilley KJ, Harding JJ. Changes in proteins of the human lens in development and aging. Biochim Biophys Acta. 1975;3862:391-408.
18. Siew EL, Opalecky D, Bettelheim FA. Light scattering of normal human lens. Ii. Age dependence of the light scattering parameters. Exp Eye Res. 1981;336:603-614.
19. Bettelheim FA, Siew EL, Chylack LT, Jr. Studies on human cataracts. Iii. Structural elements in nuclear cataracts and their contribution to the turbidity. Invest Ophthalmol Vis Sci. 1981;203:348-354.
20. Ohrloff C, Hockwin O. Lens metabolism and aging: Enzyme activities and enzyme alterations in lenses of different species during the process of aging. J Gerontol. 1983;383:271-277.
21. Andersson M, Sjöstrand J, Karlsson J-O. Proteolytic cleavage of n-succ-leu-leu-val-tyr-amc by the proteasome in lens epithelium from human clear and cataractous lenses. Exp Eye Res. 1998;67:231-236.
22. Sitte N, Huber M, Grune T, Ladhoff A, Doecke WD, Von Zglinicki T, Davies KJ. Proteasome inhibition by lipofuscin/ceroid during postmitotic aging of fibroblasts. Faseb J. 2000;1411:1490-1498.
23. Sitte N, Merker K, Von Zglinicki T, Davies KJ, Grune T. Protein oxidation and degradation during cellular senescence of human bj fibroblasts: Part ii - aging of nondividing cells. Faseb J. 2000;1415:2503-2510.
24. Sitte N, Merker K, Von Zglinicki T, Grune T, Davies KJ. Protein oxidation and degradation during cellular senescence of human bj fibroblasts: Part i - effects of proliferative senescence. Faseb J. 2000;1415:2495-2502.
25. Conconi M, Friguet B. Proteasome inactivation upon aging and on oxidation-effect of hsp 90. Mol Biol Rep. 1997;24:45-50.
26. Andersson M, Sjöstrand J, Karlsson J-O. Differential inhibition of three peptidase activities of the proteasome in human lens epithelium by heat and oxidation. Exp Eye Res. 1999;691:129-138.
27. Carlsson B, Sjostrand J. Increased incidence of cataract extractions in women above 70 years of age. A population based study. Acta Ophthalmol Scand. 1996;741:64-68.
28. Klein BEK, Klein R, Linton KLP. Prevalence of age-related lens opacities in a population. Ophthalmology. 1992;99:546-552.
29. Leske MC, Chylack LT, Wu SY, Group TLOCCS. The lens opacities case-control study: Risk factors for cataract. Arch Ophthalmol. 1991;109:244-251.
30. Taylor A, Davies KJA. Protein oxidation and loss of protease activity may lead to cataract formation in the aged lens. Free Radical Biology & Medicine. 1987;3:371-377.
31. Shang F, Palmer HJ, Nowell Jr TR, Taylor A. Age-related decline in ubiquitin conjugation in response to oxidative stress in the lens. Exp Eye Res. 1997;64:21-30.
32. Bence NF, Sampat RM, Kopito RR. Impairment of the ubiquitin-proteasome system by protein aggregation. Science. 2001;2925521:1552-1555.
33. Shringarpure R, Grune T, Sitte N, Davies KJ. 4-hydroxynonenal-modified amyloid-beta peptide inhibits the proteasome: Possible importance in Alzheimer's disease. Cell Mol Life Sci. 2000;5712:1802-1809.
34. Friguet B, Szweda LI. Inhibition of the multicatalytic proteinase (proteasome) by 4-hydroxy-2-nonenal cross-linked protein. FEBS Lett. 1997;4051:21-25.
35. Petropoulos I, Conconi M, Wang X, Hoenel B, Bregegere F, Milner Y, Friguet B. Increase of oxidatively modified protein is associated with a decrease of proteasome activity and content in aging epidermal cells. J Gerontol A Biol Sci Med Sci. 2000;555:B220-227.
36. Vittorini S, Paradiso C, Donati A, Cavallini G, Masini M, Gori Z, Pollera M, Bergamini E. The age-related accumulation of protein carbonyl in rat liver correlates with the age-related decline in liver proteolytic activities. J Gerontol A Biol Sci Med Sci. 1999;548:B318-B323.
37. Bulteau AL, Moreau M, Nizard C, Friguet B. Impairment of proteasome function upon uva- and uvb-irradiation of human keratinocytes. Free Radic Biol Med. 2002;3211:1157-1170.